Liselotte Hyveled

Member of the Board of Directors (employee representative) and member of the Research & Development Committee

Resume

Positions and management duties

  • Chief Patient Officer and Principal Vice President of Patient Voice Strategy & Alliances, Novo Nordisk A/S.
  • Member of the board of directors of TriSalus Life Sciences.

Novo Nordisk

  • Not considered independent under the Danish Corporate Governance Recommendations.
  • Employed in Novo Nordisk since 1992.
  • Employee-elected member of the Board of Directors since March 2022 for a term of four years (term expires in March 2026). Previously employee-elected member of the Board of Directors from 2014-2018.
  • Member of the Research & Development Committee since March 2022.

Education

  • 2018: Board Leadership Programme, Copenhagen Business School, Denmark.
  • 2014: Board Leadership Masterclass, Copenhagen Business School, Denmark.
  • 2011: Master of Medical Business Strategy, Copenhagen Business School, Denmark.
  • 1992: MSc, Pharmacy, University of Copenhagen, Denmark.

Nationality and age

Danish, born 1966. Female. 

Your Career Guide